Health Care & Life Sciences » Pharmaceuticals | Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. | Mutual Funds

Mutual Funds that own Sihuan Pharmaceutical Holdings Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Emerging Markets Stock Index Fund
63,581,791
0.67%
-630,000
0.02%
07/31/2018
Vanguard Total International Stock Index Fund
59,400,128
0.63%
1,533,000
0%
07/31/2018
Government Pension Fund - Global (The)
45,065,892
0.48%
13,376,795
0%
12/31/2017
iShares Core MSCI Emerging Markets ETF
35,671,000
0.38%
0
0.02%
09/05/2018
Quoniam Fds. Selection SICAV - Emerg. Mkts. Equit. MinRisk
32,453,250
0.34%
11,148,000
0.3%
03/31/2018
DFA Emerging Markets Small Cap Series
28,512,000
0.3%
0
0.09%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
24,270,000
0.26%
0
0.02%
04/30/2018
iShares MSCI Emerging Markets ETF
23,449,000
0.25%
0
0.02%
09/06/2018
Schroder Institutional QEP Global Emerging Markets Fund
17,949,000
0.19%
0
0.48%
05/31/2018
17,499,000
0.19%
0
0.99%
09/06/2018

About Sihuan Pharmaceutical Holdings Group

View Profile
Address
21/F, Building 2
Beijing Beijing 100025
China
Employees -
Website http://www.sihuanpharm.com
Updated 07/08/2019
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.